APA

Eiseman J. L., Rogers F. A., Guo Y., Kauffman J., Sentz D. L., Klinger M. F., Callery P. S. & Kyprianou N. (19981118). Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. : Cancer research.

Chicago

Eiseman J L, Rogers F A, Guo Y, Kauffman J, Sentz D L, Klinger M F, Callery P S and Kyprianou N. 19981118. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. : Cancer research.

Harvard

Eiseman J. L., Rogers F. A., Guo Y., Kauffman J., Sentz D. L., Klinger M. F., Callery P. S. and Kyprianou N. (19981118). Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. : Cancer research.

MLA

Eiseman J L, Rogers F A, Guo Y, Kauffman J, Sentz D L, Klinger M F, Callery P S and Kyprianou N. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. : Cancer research. 19981118.